November 27, 2012
In this video, Motley Fool health care analyst Brenton Flynn highlights a couple of emerging trends that medical technology investors should be watching. The first thing he has his eye on is a new procedure called renal denervation, a method to treat patients with hypertension who don't respond to medication. His second area to watch is how different pharmaceutical and biotech companies push into emerging markets, and how they address the need for more value-oriented solutions in these areas.
While you can certainly make huge gains from the binary events such as biotech drug approvals and buyout speculation, the most successful investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.